BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

Phase 1Abreu BTT 700 Temperature Management System (TMS)Positive

AI Analysis

Summary

BTT Medical Institute has launched a first-in-human safety clinical trial of the Abreu BTT 700 Temperature Management System, a brain-guided induced hyperthermia device for treating ALS and neurodegenerative disorders. The initial phase study will evaluate the system's thermofebrile protocol and lay groundwork for future efficacy trials.

Clinical Trial Data

Phase

Phase 1

Outcome Details

First-in-human safety clinical trial launched evaluating induced hyperthermia with computerized brain-guided temperature management system

Importance:5/10

Sentiment:

0.50

Clinical TrialPhase 1Neurodegenerative DiseasesALSMedical DeviceHyperthermia

Related Companies

$MDCE $FVNNU $GTHP $BNN.DE $TRAX

Read the original article

Published by GlobeNewswire Clinical Studies on August 26, 2026 12:00 PM

Read Original